Zentiva announces completion of Solacium Pharma acquisition
News from Zentiva
This section is for journalists and media professionals and contains comprehensive information about Zentiva.
-
June 4, 2019 / LinkedIn
-
May 31, 2019 / Press Releases
-
May 22, 2019 / LinkedIn
-
April 11, 2019 / LinkedIn
-
April 1, 2019 / Press Releases
Zentiva Group a.s. is announcing the acquisition of Creo Pharmaceuticals Ltd. in the UK, a subsidiary of Amneal Pharmaceuticals, Inc. (NYSE: AMRX).
-
March 13, 2019 / Press Releases
Zentiva Group a.s. and Siyiara Enterprises have signed a Shared Purchase Agreement for the acquisition of Romanian based pharmaceutical company Solacium, together with its subsidiary Be Well Pharma.
-
March 5, 2019 / Press Releases
The Parc (Pharmaceutical Applied Research Center) is marking its five-year anniversary by launching The Parc Awards at a ceremony held at Zentiva Headquarters in Prague on March 5th.
-
February 6, 2019 / Featured
For the 4th year in a row, Zentiva has been named as the most prestigious Employer in the Healthcare & Pharmacy sector in Czech Republic at the TOP Employers competition.
-
May 31, 2019 / Press Releases
Zentiva announces completion of Solacium Pharma acquisition
-
April 1, 2019 / Press Releases
Zentiva Group a.s. is announcing the acquisition of Creo Pharmaceuticals Ltd. in the UK, a subsidiary of Amneal Pharmaceuticals, Inc. (NYSE: AMRX).
-
March 13, 2019 / Press Releases
Zentiva Group a.s. and Siyiara Enterprises have signed a Shared Purchase Agreement for the acquisition of Romanian based pharmaceutical company Solacium, together with its subsidiary Be Well Pharma.
-
March 5, 2019 / Press Releases
The Parc (Pharmaceutical Applied Research Center) is marking its five-year anniversary by launching The Parc Awards at a ceremony held at Zentiva Headquarters in Prague on March 5th.
-
January 25, 2019 / Press Releases
Zentiva is investing EUR 30 million to maximize its manufacturing site capabilities in Prague.
-
January 15, 2019 / Press Releases
Zentiva is very pleased to announce the appointment of Nick Haggar to the role of Chief Executive Officer (CEO), effective as of February 11th, 2019.
-
October 1, 2018 / Press Releases
oday marks generics manufacturer Zentiva’s first day as an independent organization, following completion of the company’s previously announced divestment from Sanofi.
-
June 28, 2018 / Press Releases
Sanofi and Advent International (“Advent”) have finished negotiations for the acquisition of Zentiva, Sanofi’s European generics business, by Advent and the companies have signed a Share Purchase Agreement worth €1.9 billion (enterprise value).
-
February 6, 2019 / Featured
For the 4th year in a row, Zentiva has been named as the most prestigious Employer in the Healthcare & Pharmacy sector in Czech Republic at the TOP Employers competition.
-
November 23, 2018 / Featured
Zentiva and PHOENIX joined forces this week for an inaugural Annual Partnership meeting in Prague to kick off a strategic partnership between the two healthcare companies in Europe.
Our Visual Identity
Logo
 |
|
|
 |
Pantone |
2727 |
 |
Pantone |
339 |
Press Relations
 |
Ines WindischHead of Corporate Affairs |